Skip to main navigation Skip to search Skip to main content

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor

  • William G. Wierda
  • , John C. Byrd
  • , Matthew S. Davids
  • , Richard R. Furman
  • , Bruce D. Cheson
  • , Paul M. Barr
  • , Herbert Eradat
  • , Leonard Heffner
  • , Lang Zhou
  • , Maria Verdugo
  • , Jalaja Potluri
  • , Michael Choi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)961-966
Number of pages6
JournalBritish Journal of Haematology
Volume185
Issue number5
DOIs
StatePublished - Jun 2019

Keywords

  • B-cell receptor signalling pathway inhibitor
  • chronic lymphocytic leukaemia
  • refractory
  • relapsed
  • venetoclax

Cite this